Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

IL-17 signaling in host defense against Candida albicans.

Gaffen SL, Hernández-Santos N, Peterson AC.

Immunol Res. 2011 Aug;50(2-3):181-7. doi: 10.1007/s12026-011-8226-x. Review.

2.

Th17 cells in immunity to Candida albicans.

Hernández-Santos N, Gaffen SL.

Cell Host Microbe. 2012 May 17;11(5):425-35. doi: 10.1016/j.chom.2012.04.008. Review.

3.

Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.

Hernández-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL.

Mucosal Immunol. 2013 Sep;6(5):900-10. doi: 10.1038/mi.2012.128. Epub 2012 Dec 19.

4.

Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection.

Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S.

J Immunol. 2013 Jan 15;190(2):521-5. doi: 10.4049/jimmunol.1202924. Epub 2012 Dec 19.

5.

Recent advances in the IL-17 cytokine family.

Gaffen SL.

Curr Opin Immunol. 2011 Oct;23(5):613-9. doi: 10.1016/j.coi.2011.07.006. Epub 2011 Aug 16. Review.

6.

The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.

Bishu S, Hernández-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL.

Infect Immun. 2014 Mar;82(3):1173-80. doi: 10.1128/IAI.01335-13. Epub 2013 Dec 30.

7.

Adaptive immune responses to Candida albicans infection.

Richardson JP, Moyes DL.

Virulence. 2015;6(4):327-37. doi: 10.1080/21505594.2015.1004977. Epub 2015 Jan 21. Review.

8.

Host responses to Candida albicans: Th17 cells and mucosal candidiasis.

Conti HR, Gaffen SL.

Microbes Infect. 2010 Jul;12(7):518-27. doi: 10.1016/j.micinf.2010.03.013. Epub 2010 Apr 8. Review.

9.

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL.

J Exp Med. 2009 Feb 16;206(2):299-311. doi: 10.1084/jem.20081463. Epub 2009 Feb 9.

10.

Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils.

Romani L, Bistoni F, Puccetti P.

Chem Immunol. 1997;68:110-35. Review.

PMID:
9329219
11.

IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Conti HR, Gaffen SL.

J Immunol. 2015 Aug 1;195(3):780-8. doi: 10.4049/jimmunol.1500909. Review.

PMID:
26188072
12.

Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans.

Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y.

Immunity. 2010 May 28;32(5):681-91. doi: 10.1016/j.immuni.2010.05.001. Epub 2010 May 20.

13.

IL-22 defines a novel immune pathway of antifungal resistance.

De Luca A, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F, Puccetti P, Romani L.

Mucosal Immunol. 2010 Jul;3(4):361-73. doi: 10.1038/mi.2010.22. Epub 2010 May 5.

PMID:
20445503
14.

Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.

Huppler AR, Conti HR, Hernández-Santos N, Darville T, Biswas PS, Gaffen SL.

J Immunol. 2014 Feb 15;192(4):1745-52. doi: 10.4049/jimmunol.1302265. Epub 2014 Jan 17. Erratum in: J Immunol. 2015 Feb 1;194(3):1382.

15.

Role of IFN-gamma in immune responses to Candida albicans infections.

Gozalbo D, Maneu V, Gil ML.

Front Biosci (Landmark Ed). 2014 Jun 1;19:1279-90. Review.

PMID:
24896350
16.

The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis.

van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK, van der Meer JW, Kullberg BJ, Netea MG, Kanneganti TD.

Eur J Immunol. 2011 Aug;41(8):2260-8. doi: 10.1002/eji.201041226. Epub 2011 Jul 4.

17.

IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A.

J Immunol. 2010 Nov 1;185(9):5453-62. doi: 10.4049/jimmunol.1001153. Epub 2010 Oct 4.

18.

A Candida albicans Strain Expressing Mammalian Interleukin-17A Results in Early Control of Fungal Growth during Disseminated Infection.

Huppler AR, Whibley N, Woolford CA, Childs EE, He J, Biswas PS, McGeachy MJ, Mitchell AP, Gaffen SL.

Infect Immun. 2015 Sep;83(9):3684-92. doi: 10.1128/IAI.03057-14. Epub 2015 Jul 6.

19.

Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against Candida albicans.

Joly S, Eisenbarth SC, Olivier AK, Williams A, Kaplan DH, Cassel SL, Flavell RA, Sutterwala FS.

J Immunol. 2012 Nov 15;189(10):4713-7. doi: 10.4049/jimmunol.1201715. Epub 2012 Oct 15.

20.

Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.

Ahlgren KM, Moretti S, Lundgren BA, Karlsson I, Ahlin E, Norling A, Hallgren A, Perheentupa J, Gustafsson J, Rorsman F, Crewther PE, Rönnelid J, Bensing S, Scott HS, Kämpe O, Romani L, Lobell A.

Eur J Immunol. 2011 Jan;41(1):235-45. doi: 10.1002/eji.200939883. Epub 2010 Dec 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk